Australia · Delayed Price · Currency is AUD Chimeric Therapeutics Statistics
Total Valuation
ASX:CHM has a market cap or net worth of AUD 2.29 million. The enterprise value is -216,816.
| Market Cap | 2.29M |
| Enterprise Value | -216,816 |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CHM has 53.18 million shares outstanding. The number of shares has increased by 169.62% in one year.
| Current Share Class | 53.18M |
| Shares Outstanding | 53.18M |
| Shares Change (YoY) | +169.62% |
| Shares Change (QoQ) | +91.81% |
| Owned by Insiders (%) | 34.37% |
| Owned by Institutions (%) | 4.57% |
| Float | 33.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| PB Ratio | -0.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.50 |
Financial Efficiency
Return on equity (ROE) is -1,290.99% and return on invested capital (ROIC) is -227.95%.
| Return on Equity (ROE) | -1,290.99% |
| Return on Assets (ROA) | -26.96% |
| Return on Invested Capital (ROIC) | -227.95% |
| Return on Capital Employed (ROCE) | 365.17% |
| Weighted Average Cost of Capital (WACC) | 8.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:CHM has paid 16,158 in taxes.
| Income Tax | 16,158 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.25% in the last 52 weeks. The beta is 0.71, so ASX:CHM's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -89.25% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 38.50 |
| Average Volume (20 Days) | 215,942 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CHM had revenue of AUD 9.75 million and -18.79 million in losses. Loss per share was -0.76.
| Revenue | 9.75M |
| Gross Profit | 8.90M |
| Operating Income | -5.31M |
| Pretax Income | -18.77M |
| Net Income | -18.79M |
| EBITDA | -4.28M |
| EBIT | -5.31M |
| Loss Per Share | -0.76 |
Balance Sheet
The company has 2.50 million in cash and no debt, with a net cash position of 2.50 million or 0.05 per share.
| Cash & Cash Equivalents | 2.50M |
| Total Debt | n/a |
| Net Cash | 2.50M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | -3.03M |
| Book Value Per Share | -0.07 |
| Working Capital | -2.26M |
Cash Flow
| Operating Cash Flow | -8.49M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.03M |
| Net Borrowing | -4.10M |
| Free Cash Flow | -8.49M |
| FCF Per Share | -0.16 |
Margins
Gross margin is 91.32%, with operating and profit margins of -54.44% and -192.71%.
| Gross Margin | 91.32% |
| Operating Margin | -54.44% |
| Pretax Margin | -192.54% |
| Profit Margin | -192.71% |
| EBITDA Margin | -43.86% |
| EBIT Margin | -54.44% |
| FCF Margin | n/a |
Dividends & Yields
ASX:CHM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -169.62% |
| Shareholder Yield | -169.62% |
| Earnings Yield | -821.60% |
| FCF Yield | -371.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 22, 2026. It was a reverse split with a ratio of 0.01.
| Last Split Date | Apr 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
ASX:CHM has an Altman Z-Score of -21.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.77 |
| Piotroski F-Score | 2 |